ScanGrants

Grant Announcements

Updated grant and funding announcements for cardiovascular, diabetes, nutrition, and obesity. Announcements are updated automatically through and RSS feed.
Also check the grants from the Rural Assistance Center for more funding opportunities for nonprofits and individuals.
 
 

11th Global CardioVascular Clinical Trialists Forum Young Investigator Grant

ScanGrants - Cardiovascular -

11th Global CardioVascular Clinical Trialists Forum Young Investigator Grant

Deadline: 20 October 2014

The 11th Global CardioVascular Clinical Trialists Forum (CVCT) will take place for the first time in the US on December 5-7, 2014. It will be exceptionally hosted at the French Embassy in Washington DC.

Do you want to participate in a direct exchange with the world's leading experts in cardiovascular clinical trials? Are you mapping out your career as a trialist?

CVCT Forum encourages knowledge sharing between participants, familiarizing practitioners and young investigators with the science of clinical trials from protocol design to result interpretation.

By far, the Global CardioVascular Clinical Trialists Forum (CVCT) provides the best annual update and in-depth understanding of the trials shaping the evidence base of modern cardiology.

Take part in an exclusive event with high-level learning that you can implement immediately.

Network with the world’s leading trialists and learn about their latest successes and challenges.

Your registration fee is covered by the CVCT Forum.

Your room is pre-booked close to the venue (for two nights).

You will receive a contribution to your travel costs.

GRANT

One full scientific registration to attend CVCT (including congress materials, lunches, coffee breaks and and invitations to the networking reception) as well as two nights’ accommodation and a travel grant.

Completed grant applications must contain the following documents:

Current CV

Letter of recommendation from your program director/department head

Completed CVCT grant form

Criteria to apply:

Candidates must be under the age of 35/fellows or in their last year of residency.

Applicants are requested to submit an abstract to present as a poster at the CVCT Forum.

All grant applications must be made in writing and submitted to:

Aurélie Städtler
CVCT Project Manager
Email : cvct@overcome.fr

Please note: only complete applications will be considered.

Whole Kids Foundation School Garden Grant

ScanGrants - Nutrition -

Whole Kids Foundation School Garden Grant

October 31st at 5pm CST (6pm EST, 4pm MST, 3pm PST): Application closes.

Eligibility criteria:

1. School garden must be an edible school garden (such as growing fruits, vegetables, herbs, grains, etc) and located on the grounds of a K-12 school (public, private or charter, elementary, middle or secondary)

2. Applicant must be a nonprofit K-12 school (public, private or charter, elementary, middle or high) or a 501(c)(3) nonprofit organization working in partnership with a K-12 school.

3. Applicant cannot be a previous recipient of a Whole Kids Foundation School Garden Grant.

4. Applicant must have the participation and support of a specific partner organization from the community (such as a nonprofit, a farm, a local business, a Whole Foods store, or a garden club) that brings added support and sustainability to the initiative. The applicant, if a nonprofit, may be the community partner for this grant.

Have questions? Contact gardens@wholekidsfoundation.org!

Call for Nominations: 2016 Society for Adolescent Health and Medicine/Iris F. Litt Visiting Professorship in Adolescent Health Research

ScanGrants - Nutrition -

Call for Nominations: 2016 Society for Adolescent Health and Medicine/Iris F. Litt Visiting Professorship in Adolescent Health Research

The Society for Adolescent Health and Medicine Visiting Professorship in Adolescent Research was established in 1995 with the first award being given for 1995. The intent of this award was to provide an educational experience in Adolescent Research for a group of health care providers and researchers who might not otherwise have the opportunity to benefit from the professor’s expertise.

In 2005, the Board of Directors named this professorship in perpetuity to honor Dr. Iris F. Litt because of her substantial contributions to the field of adolescent medicine and adolescent health, as well as her tenure as the Editor-in-Chief of the Journal of Adolescent Health. In addition, the Board of Directors modified the title of this award to make it more consistent with the mission and purpose of this educational activity.

CRITERIA: The Visiting Professorship Program is intended to help clinical, research, policy and training programs that are currently engaged in clinical care of adolescents, research or policy to improve the research components to become better equipped to conduct adolescent health-focused research as well as to improve the ability of the researchers to successfully compete for funding a research program. Consultation from the visiting professor is not a substitution for an institution’s commitment to providing needed resources.

Ideally the award will be made to programs that provide advanced training in medicine, psychology, social work, nursing, nutrition, or public health programs that focus on adolescent health which can demonstrate that the visiting professorship program will enhance the research capacity of trainees, graduate or post-graduate students, faculty, and other health professionals who serve adolescents. Candidates to be considered for this Award may or may not be members of the Society for Adolescent Health and Medicine.

SELECTION PROCESS: Nominations for both the Visiting Professor and the host site are accepted from any current member of SAHM. The SAHM Awards: Research Sub-Committee is charged with selecting both the Visiting Professor and host site.

BUDGET AND ADMINISTRATION: The award is financially administered through the Society's business office. The Award includes an engraved plaque, an honorarium of $2,000, with travel expenses for award recipients reimbursed with receipts up to $1,500. The host site awarded the professorship must agree to assume responsibility for travel expenses that exceed $1,500.

DEADLINE: Applications for the 2016 SAHM/ Iris F. Litt  must be received electronically to ccody@adolescenthealth.org by no later than October 28th, 2014. The winner will be notified in January 2015  and award funds will be distributed at the SAHM Annual Meeting in Los Angeles on March 18, 2015.

The JDRF and the Helmsley Charitable Trust Request Expressions of Interest for Improved Assays for Predicting Risk for T1D

ScanGrants - Diabetes -

The JDRF and the Helmsley Charitable Trust Request Expressions of Interest for Improved Assays for Predicting Risk for T1D

JDRF and The Leona M. and Harry B. Helmlsey Charitable Trust are soliciting expressions of interest (EOI) for optimizing and validating existing technologies for predictive screening for T1D risk and autoimmunity to be applied for wide-spread use in population-based screening efforts, including newborn or childhood based screening. EOIs requesting development of new assays will not be considered.

BACKGROUND

Prevention of type 1 diabetes (T1D) represents a “cure” for those at-risk of developing the disease, and, in fact, will likely represent the most cost-effective approach to a cure and is becoming increasingly important with the rising incidence of the disease. Over the last three to four decades, the incidence of T1D has increased at an annual rate of 3-5% with penetration to low-moderate human leukocyte antigen (HLA) risk groups, suggesting a lowered threshold for its development. In some countries, the largest increase in incidence has occurred in the age group 1-5 years.

Currently, assays of islet autoantibodies (AAb) are the most robust approach to detect risk in relatives of individuals with T1D and aid in predicting progression to T1D in HLA at-risk children. Indeed , the 10-year risk of progression to symptomatic T1D with multiple islet AAbs (insulin, GAD65, IA-2 and ZnT8) is 70%. However, the current practices for AAb screening, including screening for genetic risk in neonates or screening for AAb first-degree or second-degree relatives who are known to have an increased risk, detect only 40% and 15% respectively of individuals who will progress to T1D. Only a relatively small proportion of HLA at-risk children develop T1D.

Therefore, new approaches are required to increase sensitivity and specificity of screening. Existing AAb protocols to predict risk of T1D are also costprohibitive for universal childhood screening.

Efforts are underway to better predict risk of development of autoimmunity and the earliest stages of autoimmunity using metabolomics, microbiome metagenomics, transcriptomics, and T-cell assays.

Furthermore, there are ongoing efforts to integrate and model diverse data (genetic, immunologic, metabolic, age, etc.) to develop composite predictive risk scores that better predict rate of progression.

The development of technologies to improve T1D risk detection in the general population would facilitate recruitment for clinical research focused on identifying environmental triggers and natural history of T1D, along with interventions to prevent T1D.

OBJECTIVES

Expressions of interest are sought from investigators who seek to optimize and/or validate existing platforms for use in predicting risk of T1D, both prior to and after development of AAbs. These assays should meet the following criteria for general population-based screening, which may include newborn or childhood-based screening methods:

a. Selectivity, sensitivity, ease of use

b. High-throughput capacity

c. Low volume needed

d. Low cost

e. Possibility for the assay to be deployed as point-of-care testing

Investigators with ideas or resources that might benefit this initiative should also submit their ideas via an expression of interest.

This EOI will not support the development of new technologies or assays.

ELIGIBILITY

Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent academic degree and a faculty position or equivalent at a college, university, medical school, for-profit research based organization or other comparable institution.

Applications may be submitted by domestic or foreign public or private non-profit organizations, such as colleges, universities, hospitals, laboratories, units of state or local governments or eligible agencies of the federal government.

Please note that applications from for-profit entities or industry collaborations with academia may be submitted to this EOI, however, additional information will be requested from for-profitentities if a full application is invited.

There are no citizenship requirements.

MECHANISM

EOIs in response to this announcement can be submitted to the following mechanism:

Strategic Research Agreements (supported by strong feasibility data) for a maximum budget of $200,000 per year for up to 2 years of funding (including 10% indirect costs).

Applications that are not funded in this competition may be resubmitted to other JDRF grant mechanisms according to the deadlines and guidelines described on the JDRF Web site: http://www.jdrf.org/

DEADLINES

-- Expression of Interest: September 22, 2014 (5:00pm, Eastern Time)

-- EOI Notification: October 1, 2014

-- Application Due Date: October 31, 2014 (5:00pm, Eastern Time)

-- Response to Applicants Date:  January 2015

-- Earliest Anticipated Start Date: February 2015

EOI COMPONENTS

Prospective applicants should submit an expression of interest on-line via RMS360 at
https://jdrf.smartsimple.us The EOI template located under the LOI Research Plan tab must be used to
submit.

EOI submissions will undergo expedited review. Applicants will be notified if they have been approved to submit a full application.

JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes

ScanGrants - Diabetes -

JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes

Key Dates:

August 15, 2014: Expressions of interest (EOI) release date

October 10, 2014: EOI due date

October 31, 2014: EOI decision notification

December 10, 2014: Full application due date (for accepted EOIs)

April 2015: Award notification May 2015: Earliest start date

Purpose of Request

JDRF is soliciting expressions of interest (EOI) for the discovery, development, pre-clinical or pilot clinical testing of novel antigen-specific therapeutic approaches designed to induce durable immunoregulation for human type 1 diabetes (T1D). JDRF is committed to translation of research findings towards clinical results and is most interested in projects that have clinical translation potential.

Background

Immunotherapeutic approaches for preventing or halting T1D have involved both antigen-specific and antigen non-specific interventions. Because T1D results from a failure to maintain immune tolerance to islet antigens/autoantigens, targeting the immune response to these antigens/autoantigens may provide an effective means of preventing and controlling the autoimmune response and avoid the harmful effects associated with non-specific immunosuppression. Clinical data from several independent trials has provided compelling evidence that current immunomodulatory approaches are not optimally effective at preventing T1D or at durably controlling beta cell loss in the recent onset T1D setting. In addition, islet transplantation trials show recurrence of beta cell antigen specific autoreactivity under the cover of immunosuppressive therapy.

Specific Goals of Request

Expressions of interest are sought from investigators interested in discovering and developing, or in evaluating in pre-clinical models or pilot clinical studies, novel antigen-specific therapies for T1D. Such therapies may have application for: 1) the at-risk, immunologically unprimed setting with primary prevention of T1D and/or for the immunologically primed setting with secondary prevention of T1D; 2) for control of autoimmunity in the new onset T1D setting; or 3) in combination with other immunomodulatory therapies or approaches to robustly induce immunoregulation and regenerate beta cells to restore insulin independence in the recent onset and established T1D setting. The clinical translation potential of the investigations should be emphasized. Of interest are also mechanistic studies and biomarker discovery/validation around antigen-specific T1D clinical trials.

Examples of pertinent topics include, but are not limited to:

-- Discovery of novel antigen-specific therapies for T1D

-- Validate and further develop existing antigen-specific approaches to enable and accelerate their clinical translation

-- Dose finding studies, differences in unprimed vs. primed autoimmune responses, optimization of treatment regimens, and in silico modeling

-- Elucidate mechanisms of action of antigen-specific approaches to improve efficacy and refine the therapeutic strategy.

-- Mechanistic studies for ongoing or recently completed antigen-specific clinical trials in T1D

-- Pilot clinical trials of antigen-specific efficacy using a single agent or combination agents as measured by short-term mechanistic endpoints that reflect robust immune-regulation. Please note that JDRF recently released an EOI for Combination Therapies in Type 1 Diabetes. This EOI is not meant as a replication of that EOI, and EOIs that were submitted to that mechanism will not be considered here.

-- Investigators with ideas or resources that might benefit this initiative should also submit their ideas via an expression of interest.

Levels of Funding and Grant Mechanisms:

Applications in response to this announcement can be submitted under one of the following three funding mechanisms:

-- Innovative Grants: up to $110,000 (including 10% indirect costs) for one year only.

-- Strategic Research Agreements (SRAs): up to $250,000/yr (including 10% indirect costs) for up to two years.

For any research projects proposed for 3 years, applicants must contact JDRF to discuss its scientific justification. For any budget that exceeds $250,000/yr, JDRF scientific staff must be contacted with a strong justification, prior to EOI submission. SRAs require quarterly milestones, reporting against those milestones and will receive milestone-based payments.

-- Clinical grants for pilot trials: up to $1,000,000 total costs (including 10% indirect costs) for a maximum of 3 years. For any trials proposed for greater than 3 years or for a larger budget, JDRF scientific staff must be contacted prior to EOI submission. Clinical awards require pre-established milestones and will receive milestone-based payments.

-- For all submissions, proposed budgets should be well-justified and commensurate with the type of study and the research plan.

Verizon Foundation Grant Program

ScanGrants - Diabetes -

Verizon Foundation Grant Program

The Verizon Foundation’s primary philanthropic focus areas are: Healthcare for children, women and seniors; STEM education for K-12 youth and Energy Management. Grant applications are by invitation only and are reviewed from February 3, 2014 through midnight on October 10, 2014. Please contact your local Verizon Community Relations Manager to learn more.

Healthcare-related Programs

Verizon Foundation is leveraging its technology and resources to improve quality and access for children, women and seniors in rural and urban communities in need. Our main focus is to reduce healthcare disparities, improve access and quality, and enable better chronic disease outcomes through health information technology that educates and empowers patients to self-manage their health.

Improving Access for Children

We use technology to connect children to better healthcare, reducing the impact of chronic disease in our most vulnerable communities. We partner with innovative organizations who aim to reduce the impact and disparities of obesity, diabetes & asthma as chronic conditions through technology to help kids get and stay healthy

Empowering Health for Women

Due to a lack of regular access to care along with other factors, women are frequently diagnosed later with chronic diseases than men, and experience higher fatality rates. That is why we support partnerships that highlight the role technology can play in in increasing access  to care and chronic disease management for underserved women.

Connecting Health for Seniors

We connect healthcare providers, patients and care-givers to create innovative care models, enabling seniors with chronic disease to age in place.  We support the work of our partners nationwide in this endeavor.

Domestic Violence Prevention

We invest in organizations that provide education, prevention, care for victims and empowerment resources.

Verizon Foundation Grant Program

ScanGrants - Obesity -

Verizon Foundation Grant Program

The Verizon Foundation’s primary philanthropic focus areas are: Healthcare for children, women and seniors; STEM education for K-12 youth and Energy Management. Grant applications are by invitation only and are reviewed from February 3, 2014 through midnight on October 10, 2014. Please contact your local Verizon Community Relations Manager to learn more.

Healthcare-related Programs

Verizon Foundation is leveraging its technology and resources to improve quality and access for children, women and seniors in rural and urban communities in need. Our main focus is to reduce healthcare disparities, improve access and quality, and enable better chronic disease outcomes through health information technology that educates and empowers patients to self-manage their health.

Improving Access for Children

We use technology to connect children to better healthcare, reducing the impact of chronic disease in our most vulnerable communities. We partner with innovative organizations who aim to reduce the impact and disparities of obesity, diabetes & asthma as chronic conditions through technology to help kids get and stay healthy

Empowering Health for Women

Due to a lack of regular access to care along with other factors, women are frequently diagnosed later with chronic diseases than men, and experience higher fatality rates. That is why we support partnerships that highlight the role technology can play in in increasing access  to care and chronic disease management for underserved women.

Connecting Health for Seniors

We connect healthcare providers, patients and care-givers to create innovative care models, enabling seniors with chronic disease to age in place.  We support the work of our partners nationwide in this endeavor.

Domestic Violence Prevention

We invest in organizations that provide education, prevention, care for victims and empowerment resources.

UltraEcho, Ltd. Cardiovascular Student Travel Grant

ScanGrants - Cardiovascular -

UltraEcho, Ltd. Cardiovascular Student Travel Grant

The American Society of Echocardiography Education and Research Foundation (ASEF) is pleased to announce the availability of a travel grant for a sonography student enrolled in an accredited CAAHEP cardiovascular ultrasound program.  The travel grant program is designed to provide partial financial support to a sonography student who would otherwise be unable to attend the ASE 26th Annual Scientific Sessions in Boston, MA, June 13-16, 2015, or any other 2015 educational courses directly sponsored by ASE.  A complimentary registration fee is included with the travel grant award, along with a one year student membership in the American Society of Echocardiography.

This travel grant is based on financial need.ASEF thanks UltraEcho, Ltd. for sponsoring this annual student travel grant.

Award Amount  $1,000.00

Application Receipt Deadline:  November 30, 2014

Award Announcement:  February 2015

Award Payment Date:  February 2015

To Apply:

*  Complete the on-line UltraEcho, Ltd. Cardiovascular Sonographer Student Travel Grant form.

Criteria for Award:

*  Students must be actively enrolled in  cardiovascular ultrasound programs accredited by the commission on Accreditation of Allied Health Education Programs (CAAHEP) or in equivalent Canadian or international cardiovascular ultrasound programs* at the time of the grant selection.  Students graduating in the Spring/Summer of 2015 are eligible to apply.

*   International candidates will need to submit information describing equivalency of program to CAAHEP standards and/or course work that follows the National Education Curriculum (NEC).

*  This travel grant is based on financial need.  While any sonography student actively enrolled in a CAAHEP cardiovascular program may apply for this travel support, the selection process will give preference to students without sufficient travel funding and who would not otherwise be able to attend an educational course directly sponsored by ASE.  If selected to receive an ASEF student travel grant, the student will be requested to provide a written testimonial and personal photo for use in promotional materials and/or on ASEF’s website.

Students who are nominated for an Alan D. Waggoner Student Scholarship Award may also apply for the UltraEcho, Ltd. Cardiovascular Student Travel Grant and the Feigenbaum Student Travel grant; however, a student will only be selected for one award.

Feigenbaum Cardiovascular Student Travel Grant

ScanGrants - Cardiovascular -

Feigenbaum Cardiovascular Student Travel Grant

The American Society of Echocardiography Education and Research Foundation (ASEF) is pleased to announce the availability of a travel grant for a sonography student enrolled in an accredited CAAHEP cardiovascular ultrasound program.  The travel grant program is designed to provide partial financial support to sonography students who would otherwise be unable to attend the ASE 26th Annual Scientific Sessions in Boston, MA, June 13-16, 2015, or any other 2015 educational course directly sponsored by ASE.  A complimentary registration fee is included with the travel grant award, along with a one year student membership in the American Society of Echocardiography.

ASEF thanks Elsevier Inc. for supporting this grant to honor Dr. Harvey Feigenbaum’s commitment and tenure as the former editor of the Journal of the American Society of Echocardiography (JASE) for 20 years.

Award Amount  $1,000.00

Application Receipt Deadline  November 30, 2014

Award Announcement  February 2015

Award Payment Date:  February 2015

To Apply:

*  Complete the online Feigenbaum Cardiovascular Sonographer Student Travel Grant form.

Criteria for Award:

*  Students must be actively enrolled in  cardiovascular ultrasound programs accredited by the commission on Accreditation of Allied Health Education Programs (CAAHEP) or in equivalent Canadian or international cardiovascular ultrasound programs* at the time of the grant selection.  Students graduating in the Spring/Summer of 2015 are eligible to apply.

* International candidates will need to submit information describing equivalency of program to CAAHEP standards and/or course work that follows the National Education Curriculum (NEC).

*  This travel grant is based on financial need.  While any sonography student actively enrolled in a CAAHEP cardiovascular program may apply for this travel support, the selection process will give preference to students without sufficient travel funding and who would not otherwise be able to attend an educational course directly sponsored by ASE.  If selected to receive an ASEF student travel grant, the student will be requested to provide a written testimonial and personal photo for use in promotional materials and/or on ASEF’s website.

Students who are nominated for an Alan D. Waggoner Student Scholarship Award may also apply for the UltraEcho, Ltd. Cardiovascular Student Travel Grant and the Feigenbaum Student Travel grant; however, a student will only be selected for one award.

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

ScanGrants - Diabetes -

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

Deadline: September 22, 2014

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.   Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

Scientific quality of the project;

Relevance to the research focus as described above;

Qualifications and commitment of the applicant; and

The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

Will pursue clinical research training and experience directly involving patients or human subjects.

Have had no more than two years of prior full-time research experience either in clinical or basic research.

Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2015 and run through June 30, 2016.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

For questions, please contact Kristin West at kwest@acc.org or 800-253-4636, ext. 6538.

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

ScanGrants - Cardiovascular -

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

Deadline: September 22, 2014

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.   Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

Scientific quality of the project;

Relevance to the research focus as described above;

Qualifications and commitment of the applicant; and

The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

Will pursue clinical research training and experience directly involving patients or human subjects.

Have had no more than two years of prior full-time research experience either in clinical or basic research.

Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2015 and run through June 30, 2016.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

For questions, please contact Kristin West at kwest@acc.org or 800-253-4636, ext. 6538.

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

ScanGrants - Obesity -

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders

Deadline: September 22, 2014

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.   Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

Scientific quality of the project;

Relevance to the research focus as described above;

Qualifications and commitment of the applicant; and

The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

Will pursue clinical research training and experience directly involving patients or human subjects.

Have had no more than two years of prior full-time research experience either in clinical or basic research.

Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2015 and run through June 30, 2016.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

For questions, please contact Kristin West at kwest@acc.org or 800-253-4636, ext. 6538.

Preventive Cardiovascular Nurses Association 2015 Annual Symposium Scholarship

ScanGrants - Cardiovascular -

Preventive Cardiovascular Nurses Association 2015 Annual Symposium Scholarship

Each year, PCNA allocates a portion of its resources to support scholarships for members to attend the PCNA Annual Symposium. Selection for this scholarship will be based on academic and career achievement as well as financial need. This scholarship will cover full conference registration fees and materials.

Criteria

To be eligible for this scholarship, one must:

Be a current member or join PCNA

Provide current CV

Demonstrate financial need

Agree to provide PCNA with a report within six (6) months after the conference describing the impact this program had made on your education, research, practice, and/or leadership development. The PCNA National Office will include this report along with acceptance packet, if selected.

2015 Submissions open September 1, 2014 and close November 1, 2014 at 11:59 p.m. EST

Robert M. Berne Distinguished Lectureship of the American Physiological Society Cardiovascular Section

ScanGrants - Cardiovascular -

Robert M. Berne Distinguished Lectureship of the American Physiological Society Cardiovascular Section

The Robert M. Berne Distinguished Lectureship of the APS Cardiovascular Section ($1,000 plus complimentary registration to the 2015 EB meeting) is in honor of one of the most distinguished members of the Cardiovascular Section, Robert M. Berne, whose research focused on the local chemical regulation of tissue blood flow, with an emphasis on understanding the role of adenosine and how it elicits vasodilation. This award is presented to a emerging leader in cardiovascular research whose current research is particularly stimulating, such that the presentation of this work would contribute to interest in, and growth of, the Cardiovascular Section. The applicant need not be a current member or fellow of the CV Section but should be at a peak career stage of research innovation and productivity, typically in mid-career.

The Berne Lectureship awardee will receive a $1,000 honorarium, a lecture describing their research, plus complimentary registration to the EB meeting at which they present their lecture.

Required Documents include: 1) NIH-style biosketch with 15 most representative publications; 2) two letters of nomination.

Eligible individuals should submit their application electronically through the APS website by February 2, 2015 to be considered for the 2016 award.

Application package:

-NIH-style biosketch with 15 most prominent publications

-2 Letters of Nomination: one from a past or current trainee, and the other of the applicant’s choice

American Physiological Society Cardiovascular Section Carl J. Wiggers Award

ScanGrants - Cardiovascular -

American Physiological Society Cardiovascular Section Carl J. Wiggers Award

The Carl J. Wiggers Award is in honor of the Cardiovascular Section's founder, Carl J. Wiggers, whose research defined fundamental pressure-flow relationships in the cardiovascular system. In addition to publishing definitive texts in circulatory physiology, Dr. Wiggers founded Circulation Research and trained numerous future department heads as well as several presidents of the APS.

The Wiggers award honors a scientist and fellow of the APS Cardiovascular Section who has made distinguished achievements and contributions to cardiovascular research throughout their career, has been an active and committed member of the section, and who will attract outstanding new members to the Cardiovascular Section from the United States and abroad.

The Wiggers awardee will receive a $1,000 honorarium, a featured topic selected by the awardee plus complimentary registration to the EB Meeting at which the featured topic is presented.

The nomination package should include: 1) NIH-style biosketch with 15 most representative publications and 2) two letters of nomination.

All application materials must be submitted by February 2, 2015 to be considered for the 2016 award.

Application package:

-NIH-style biosketch with 15 most prominent publications

-2 Letters of Nomination: one from a past or current trainee, and the other of the applicant’s choice

American College of Cardiology Young Investigator Awards Competition

ScanGrants - Cardiovascular -

American College of Cardiology Young Investigator Awards Competition

The Young Investigator Awards competition encourages and recognizes young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. The submission deadline is September 15, 2014. Enter your submission today and plan to attend the YIA sessions at ACC.15 for cutting-edge presentations in each of the following categories:

1. Clinical Investigations, Congenital Heart Disease and Cardiac Surgery

2. Physiology, Pharmacology and Pathology

3. ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology

4. Cardiovascular Health Outcomes and Population Genetics

The Award: The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1,500 will be reimbursed for all 20 finalists to attend the YIA Competition at ACC.15 in San Diego, CA.

Funding Source: Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CV Path Institute and the family of Herman K. Gold.

For more information: Email Kristin Robertson or call 800-253-4636, ext. 6390.

American Gastroenterological Association Student Research Fellowship Awards/AGA-Eli and Edythe Broad Student Research Fellowship(s)

ScanGrants - Nutrition -

American Gastroenterological Association Student Research Fellowship Awards/AGA-Eli and Edythe Broad Student Research Fellowship(s)

Awards are offered to support high school, undergraduate, graduate and medical school students performing digestive disease or nutrition research for a minimum of 10 weeks.

Eligibility: High School, Undergraduate, Medical and Graduate School Students

Amount/year: $2,500/$3,000

Duration: 10 weeks

Deadline: Feb. 13, 2015

Start Date: June 1, 2015

This fellowship offers $2,500 stipends to high school and undergraduate students and $3,000 to medical and graduate students to spend time performing research in digestive diseases or nutrition for a minimum of 10 weeks. As a summer fellowship, the research must take place between May and August.

Objective

The overall objective of this award is to stimulate interest in research careers in digestive diseases by providing monetary support for research projects.

Eligibility

• Candidate must be a high school, undergraduate, medical or gradate student attending an accredited North American institution.

• Candidates may not hold similar salary support awards from other agencies (such as the American Liver Foundation, Crohn’s and Colitis Foundation of America).

•The award is not intended to provide salary for laboratory technicians.

•Past recipients may reapply for continuous funding provided they submit a progress report indicating how this funding will further his/her research.

Requirements

• The awards are provided to students performing research supervised by a preceptor for a minimum of 10 weeks.

• A letter of recommendation from a past or current teacher or supervisor is required.

• Indirect costs are not allowed. The award is paid directly to the student and is to be used as a stipend.

• A scientific progress report is required upon completion of the fellowship.

• High school recipients, Broad Scholars, are required to acknowledge the AGA-Eli and Edythe Broad Student Research Fellowship(s) in all testimonials and in the event that publications, abstracts and/or presentations result from this award. All other students must acknowledge the AGA Student Research Fellowship Awards in testimonials, publications, abstracts and/or presentations that result from the award.

• Recipients of this award will be recognized at the Researcher Recognition Celebration during DDW.

Preceptor

The preceptor must be a full-time faculty member who directs a research program in a gastroenterology-related area at an accredited North American institution. The preceptor must provide a statement indicating his/her involvement in the completion of the application, his/her training record and the student's role in the study. In addition, the preceptor must be an AGA member at the time of the candidate’s application submission.

Selection Criteria and Review Process

Members of the AGA Research Award Panel will facilitate the grant review and select the award recipients. Award recipient selection will be based upon novelty, feasibility and significance of the proposal, attributes of the candidate, the record of the preceptor, evidence of institutional commitment, and the laboratory environment.

Abstract Submission

Students who receive an award are encouraged (but not required) to submit abstracts for presentation at Digestive Disease Week (DDW), the world’s largest gathering of clinicians, educators and researchers in gastrointestinal and hepatic disease and function. If a recipient’s abstract is accepted for presentation, he/she will be eligible to apply for the AGA Research Foundation Student Abstract Prize, a $500–$1,000 travel award to cover expenses to attend DDW. To submit an abstract for consideration, go to the DDW website and click on “Abstract Submission.”

Application Process

The completed application, letters of support or commitment, and other documents, as required, must be combined into and submitted as one PDF file. The document must be titled by the applicant’s last name and first initial only. Hard copies will not be accepted; please email your application, including the applicant's full name and project title. Please direct all questions to the research awards manager, by telephone at 301-222-4012 or via email.

Support of this program by The Broad Foundation is gratefully acknowledged.

American Gastroenterological Association Investing in the Future Student Research Fellowship

ScanGrants - Nutrition -

American Gastroenterological Association Investing in the Future Student Research Fellowship

Eligibility: Students

Amount/year: $5,000

Duration: 2.5 Months

Deadline: Feb. 6, 2015

Start Date: April 1, 2015

This fellowship provides 10 awards at $5,000 for underrepresented minority undergraduate and medical school students to perform eight to 10 weeks of research related to digestive diseases or nutrition. Highly qualified students will travel out of state to work with top investigators in the fields of gastroenterology and hepatology. The award amount includes housing, travel and a stipend.

Objective

The objective of this award is to stimulate interest among underrepresented minority students in digestive disease and nutrition research.

Eligibility

• Underrepresented minority (URM) students from accredited US Institutions may apply. Eligible candidates will include African Americans, Hispanic/Latino Americans, American Indians, Alaska Natives and Natives of the U.S. Pacific Islands.

• Candidates may not hold similar salary support awards from other agencies (e.g. American Liver Foundation, Crohn’s and Colitis Foundation of America, etc.).

• This award is not intended to provide salary support for laboratory technicians.

• Past recipients of the AGA Student Research Fellowship Award may reapply for continuous funding provided a scientific progress report was submitted for the previous project and other eligibility requirements are met.

Selection Criteria and Review Process

• Applicants will select and rank in order of preference three mentors from the Investing in the Future mentor roster.

Members of the AGA Research Awards Panel and the Investing in the Future Program Mentors will select the award recipients.

Requirements

• Award recipient must secure his/her housing for the duration of the fellowship.

• A scientific progress report is required upon completion of the fellowship.

• Award recipients are required to acknowledge the AGA Investing in the Future Student Research Fellowship and the National Institute of Diabetes and Digestive and Kidney Diseases (R25DK096968) in all testimonials publications, abstracts and/or presentations that result from the award.

•Recipients of this award will be recognized at the Researcher Recognition Celebration during DDW.

Abstract Submission

Award recipients are encouraged (but not required) to submit abstracts for presentation at Digestive Disease Week (DDW), the world’s largest gathering of clinicians, educators and researchers in gastrointestinal and hepatic disease and function. If a recipient’s abstract is accepted by the AGA for presentation, he/she may apply for the AGA Student Abstract Prize, a $500 travel award to attend DDW. To submit an abstract for consideration, visit the DDW website and select “Abstract Submission”.

Application Submission Instructions

The application deadline is Feb. 7. The completed application, transcript and reference letters must be combined into and submitted as one PDF file. The document must be titled by the applicant’s last name and first initial only. Hard copies will not be accepted; please email your application, including the applicant's full name and the name of the award. Please direct all questions to the research awards manager, by telephone at 301-222-4012 or via email.

For more information about this award and other research funding opportunities, visit the AGA Research Foundation page.

Request for Applications: American Heart Association 2014 Strategically Focused Hypertension Research Network

ScanGrants - Cardiovascular -

Request for Applications: American Heart Association 2014 Strategically Focused Hypertension Research Network

The Strategically Focused Research Network will focus on Hypertension.

The AHA is interested in the science community exploring all aspects of hypertension, which can assist the AHA in reaching its 2020 Goals and overall mission of building healthier lives free of cardiovascular disease and stroke.

A Network is comprised of three to four institutions, or Centers, working on three projects each that are focused on one strategic area.

To that end, the AHA pursues research from the basic, clinical and population sciences. This RFA will require that each submission have an overall application from the Center Director, as well as three proposals from project Principal Investigators in this specific area:

One proposal addressing basic science discovery in Hypertension

One proposal addressing clinical science discovery in Hypertension

One proposal addressing population science discovery in Hypertension

A Center application can comprise projects from more than one institution. The sponsoring institution will be determined by where the Center Director is located and will be charged with oversight and financial responsibilities of the Center as a whole. Applications should convey how these different areas of science will be integrated, both in their scientific discoveries and through joint team communication and integration.

Institutions are limited to one Center application per location, however individuals at said institution who are not participating in said institution's Center application, may indeed participate in another Center's application.

Offered by: AHA National Research Program

The deadline for the Letter of Intent is August 1, 2014.

The application deadline is November 3, 2014.

Call for Visiting Scientist Scholarship Applications 2014: Danish Diabetes Academy

ScanGrants - Diabetes -

Call for Visiting Scientist Scholarship Applications 2014: Danish Diabetes Academy

Online submission of applications for Visiting Scientist scholarships from the Danish Diabetes Academy is now open with registration deadline September 9, 2014. Researchers at Post Doc level, Assistant Professors or Professors can apply for a scholarship covering expenses related to international scientists visiting a Danish research group for 1-6 months.

Grants

The Danish Diabetes Academy will cover expenses for visits lasting up to 6 months including salary, transportation and rent.

Before you apply

Please note that applicants must:

Have a PhD degree

Have postdoctoral experience

Have an excellent academic record

Be able to document teaching experience

Be able to document intended collaboration with a scientific member of the Danish Diabetes Academy

Be willing to teach/ give lectures and/ or write reviews for the Danish Diabetes Academy

Application deadline

9 September 2014 (12:00 noon)

Further information

Contact: tel. 6541 3960/ e-mail info@danishdiabetesacademy.dk

Pages

Subscribe to PlantBasedResearch.org aggregator - ScanGrants